Ablatherm

Definition & Etymology

Ablatherm is the trade name for a medical device that utilizes High-Intensity Focused Ultrasound (HIFU) for the non-invasive thermal ablation of tissue. The name is a portmanteau of “ablation” (from Latin ablatus, to carry away), referring to tissue destruction, and “therm” (from Greek thermē, heat), indicating the mechanism. The device focuses multiple beams of ultrasound energy onto a precise focal point within the body. This concentration of energy rapidly elevates the temperature at the target to approximately 85-100°C, causing irreversible cell damage and coagulative necrosis, thereby destroying the targeted tissue without the need for surgical incisions.

Clinical Significance

In clinical practice, Ablatherm is primarily employed as a therapeutic modality for the treatment of localized prostate cancer. It serves as a minimally invasive alternative to traditional treatments such as radical prostatectomy and radiation therapy. The procedure is performed under anesthesia, with a transrectal probe delivering the focused ultrasound energy. Its key advantages include a potentially lower risk of certain side effects, such as incontinence and erectile dysfunction, a shorter recovery period, and the possibility of being repeated if necessary. It is often considered for patients with early-stage, organ-confined disease or as a salvage therapy for cancer recurrence after radiation failure.

Related Conditions

The principal condition treated with the Ablatherm system is localized prostate cancer, typically in stages T1-T2, where the tumor has not metastasized beyond the prostate capsule. It is also a valuable option for treating recurrent prostate cancer in patients who have previously undergone radiation therapy (salvage HIFU). While the underlying HIFU technology is being investigated for other solid tumors and conditions like benign prostatic hyperplasia (BPH) and uterine fibroids, the Ablatherm brand is specifically associated with and optimized for urological applications, particularly prostatic disease.

Key Takeaways

• Ablatherm is a brand name for a High-Intensity Focused Ultrasound (HIFU) system used for thermal tissue ablation.
• Its primary clinical application is the minimally invasive treatment of localized or recurrent prostate cancer.
• The technology works by delivering concentrated thermal energy to a precise focal point, causing targeted cell death (coagulative necrosis) while sparing surrounding healthy tissue.

Note: This content is for informational purposes only and does not substitute for professional medical advice. Always consult your doctor for diagnosis and treatment.